Home Salix Pharmaceuticals

Salix Pharmaceuticals

acquired
IPO Delisting
Gastrointestinal Disease Treatment Pharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Salix Pharmaceuticals is a specialized pharmaceutical company dedicated to the prevention and treatment of gastrointestinal (GI) diseases. For more than 20 years, they have licensed, developed, and marketed innovative products to address GI issues. Their mission is to provide the most effective solutions in gastroenterology for healthcare providers and patients.
Salix Pharmaceuticals, Inc.
NorthCarolina,United States of America
more than 500 people
January 01, 1989
salixmc@dlss.com

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services Biological Drug Production
Technology
Biotechnology
Concept
Digestive System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs